≡ Risteys
R14

Documentation Changelog GitHub Contact & Feedback
info icon

This is a non-core endpoint: only basic statistics are computed.

Malignant neoplasm of other and unspecified urinary organs

DOID Endpoint Browser

C3_URINARY_TRACT_NAS

Endpoint definition

↥

Report an error or suggest an improvement for this endpoint codes

Endpoint definition steps

FinnGen

Phenotype data

557745

1. Apply sex-specific rule

None

557745

2. Check conditions

None

557745

3. Check pre-conditions, main-only, mode, registry filters

Registry filters:

  • Cause of death: ICD-10 — C68
  • Cause of death: ICD-9 — 189[4-9]
  • Cause of death: ICD-8 — 1899
  • Cancer registry: Topography ICD-O-3 — C68
  • Cancer registry: Morphology ICD-O-3 — ANY
  • Cancer registry: Behaviour codes — 3

2 out of 7 registries used, show all original rules.

130

4. Check minimum number of events

None

130

5. Include endpoints

None

130

6. Filter based on genotype QC (FinnGen only)

111

Control definitions (FinnGen only)

Control exclude
C3_CANCER, C3_CANCER_WIDE

Extra metadata

Level in the ICD hierarchy
3
First used in FinnGen datafreeze
DF9

Case counts by codes

↥

FinnGen case counts by registry codes:

generic upset plot

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

-FinnGen-

Key figures

All Female Male
Number of individuals 111 29 82
Unadjusted period prevalence (%) 0.03 0.01 0.04
Median age at first event (years) 74.09 71.06 75.16

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

Not a core endpoint, no data to show.

CodeWAS

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.

Matched cohort

Matched cases
119
Matched controls
1190
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
UKC02
NOMESCO Finland
Cystoscopy
30.6
73.2
97
150
C67.8
ICD-10 Finland
Malignant neoplasm: Overlapping lesion of bladder
+∞
64.6
56
*
KCD02
NOMESCO Finland
Transurethral resection of bladder
701.8
49.1
45
*
R31
ICD-10 Finland
Unspecified haematuria
13.9
48.1
66
98
8120/3-C68.9
ICD-O-3
Transitional cell carcinoma, NOS, of urinary system, NOS
+∞
45.8
41
*
130
Kela drug reimbursment
Malignant tumour
+∞
44.6
40
*
JN4AD
NOMESCO Finland
Body CT examination
14.2
36.9
40
41
H02AB02
ATC
dexamethasone; systemic
150.5
32.6
33
*
A03FA01
ATC
metoclopramide; systemic, rectal
10.5
31.7
44
63
C65
ICD-10 Finland
Malignant neoplasm of renal pelvis
+∞
30.5
28
*
C68.0
ICD-10 Finland
Malignant neoplasm: Urethra
+∞
29.4
27
*
C67.9
ICD-10 Finland
Malignant neoplasm: Bladder, unspecified
+∞
29.4
27
*
KCD05
NOMESCO Finland
Excision of bladder lesion during urinary tract endoscopy with photodynamic diagnosis (PDD)
362.1
29.1
28
*
KBJ10
NOMESCO Finland
Cutaneous ureteroenterostomy
+∞
28.2
26
*
Z51.5
ICD-10 Finland
Palliative care
10.7
26.6
34
43
UKC05
NOMESCO Finland
Cystoscopy and bladder biopsy
164.6
25.7
26
*
C61
ICD-10 Finland
Malignant neoplasm of prostate
+∞
24.9
23
*
8140/3-C61.9
ICD-O-3
Adenocarcinoma, NOS, of prostate gland
+∞
24.9
23
*
UKB02
NOMESCO Finland
Retrograde ureteroscopy
156.6
24.6
25
*
B01AB10
ATC
tinzaparin; parenteral
9.9
23.3
31
41
D41.4
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Bladder
98.8
22.6
24
*
C66
ICD-10 Finland
Malignant neoplasm of ureter
+∞
21.5
20
*
8120/3-C68.0
ICD-O-3
Transitional cell carcinoma, NOS, of urethra
+∞
21.5
20
*
KAC20
NOMESCO Finland
Nephroureterectomy
+∞
21.5
20
*
C79.8
ICD-10 Finland
Secondary malignant neoplasm of other specified sites
+∞
20.4
19
*
WX408
NOMESCO Finland
General anesthesy, balanced
5.9
20.3
55
152
KCD32
NOMESCO Finland
Cystoscopic destruction of tumour of bladder
119.1
19.2
20
*
J01EA01
ATC
trimethoprim; systemic
5.5
18.6
53
151
N13.3
ICD-10 Finland
Other and unspecified hydronephrosis
38.0
17.8
22
7
ZX136
NOMESCO Finland
Intravesicalis
+∞
17.1
16
*
WF049
NOMESCO Finland
Radiotherapy of metastasis
+∞
17.1
16
*
WX602
NOMESCO Finland
Repeated or continuing anesthesia shots throug a catheter
20.7
17.0
25
15
KBV02
NOMESCO Finland
Cystoscopic insertion of stent into ureter
29.5
16.7
22
9
KH1BT
NOMESCO Finland
Urinary tract cathetrisation with X-ray guidance
70.0
16.3
18
*
8120/3-C68.8
ICD-O-3
Transitional cell carcinoma, NOS, of overlapping lesion of urinary organs
+∞
16.0
15
*
WX302
NOMESCO Finland
Thoracal epidural anesthesy
24.2
15.8
22
11
KH1AE
NOMESCO Finland
Urinary tract ultrasound examination
7.1
15.7
27
47
N10
ICD-10 Finland
Acute tubulo-interstitial nephritis
5.0
15.3
45
129
KH1CD
NOMESCO Finland
Very extensive urinary tract ultrasound examination
91.7
15.0
16
*
A04AA02
ATC
granisetron; systemic, transdermal
+∞
14.9
14
*
C68.9
ICD-10 Finland
Malignant neoplasm: Urinary organ, unspecified
+∞
14.9
14
*
WD125
NOMESCO Finland
Demanding cystostatic therapy of methastized malignancy
+∞
14.9
14
*
J01MA02
ATC
ciprofloxacin; systemic
4.4
14.0
75
334
KCC10
NOMESCO Finland
Cystoprostatectomy
+∞
13.8
13
*
ZX012
NOMESCO Finland
Radiotherapy with large shaped fields - isocentric therapy
+∞
13.8
13
*
C67.2
ICD-10 Finland
Malignant neoplasm: Lateral wall of bladder
+∞
13.8
13
*
D41.1
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Renal pelvis
157.2
13.8
14
*
WF002
NOMESCO Finland
Radical radiotherapy
157.2
13.8
14
*
JN3AE
NOMESCO Finland
Abdominal ultrasound examination
5.6
13.6
31
71
XKD00
NOMESCO Finland
Uroflowmetry
4.4
13.1
46
150
XX3DW
NOMESCO Finland
Time consuming IT work
11.7
13.0
24
25
WF004
NOMESCO Finland
Palliative radiotherapy
+∞
12.7
12
*
D41.3
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Urethra
+∞
12.7
12
*
A04AA01
ATC
ondansetron; systemic, rectal
20.9
12.5
18
10
JN4CD
NOMESCO Finland
Very extensive body CT
26.1
11.9
16
7
WZC00
NOMESCO Finland
Treatment plan or consultation
4.1
11.8
45
154
KAC21
NOMESCO Finland
Percutaneous endoscopic nephroureterectomy
+∞
11.6
11
*
8000/3-C68.9
ICD-O-3
Neoplasm, malignant of urinary system, NOS
+∞
11.6
11
*
TKC20
NOMESCO Finland
Catheterisation of bladder
5.5
11.6
26
58
R33
ICD-10 Finland
Retention of urine
4.4
11.2
35
103
C67.0
ICD-10 Finland
Malignant neoplasm: Trigone of bladder
+∞
10.6
10
*
116
Kela drug reimbursment
Prostate cancer
+∞
10.6
10
*
PJD54
NOMESCO Finland
Block dissection of iliac lymph nodes
+∞
10.6
10
*
J01MA12
ATC
levofloxacin; systemic
3.8
10.2
43
156
J01CA08
ATC
pivmecillinam; oral
3.6
10.2
47
181
WZC30
NOMESCO Finland
Teaching
4.5
10.2
29
79
N30.0
ICD-10 Finland
Acute cystitis
4.3
10.0
31
90
WX402
NOMESCO Finland
General anaesthesia
4.1
9.8
33
102
KH1BD
NOMESCO Finland
Extensive urinary tract CT examination
108.3
9.6
10
*
N02AA05
ATC
oxycodone; systemic
3.8
9.5
38
132
WC305
NOMESCO Finland
Simple therapy of local tumor recidive with biomodifiers
+∞
9.5
9
*
KCC30
NOMESCO Finland
Cystectomy with excision of female internal genital organs
+∞
9.5
9
*
C78.0
ICD-10 Finland
Secondary malignant neoplasm of lung
+∞
9.5
9
*
TPH07
NOMESCO Finland
Cathetrisation of artery
4.4
9.4
27
74
KA1AE
NOMESCO Finland
Kidney ultrasound examination
15.7
8.9
14
10
TPH04
NOMESCO Finland
Cathetrisation of vein
3.5
8.6
39
147
ZXE30
NOMESCO Finland
More than five and less than seven hours
9.2
8.4
17
21
8070/3-C68.0
ICD-O-3
Squamous cell carcinoma, NOS, of urethra
+∞
8.4
8
*
UKA02
NOMESCO Finland
Retrograde ureteronephroscopy
+∞
8.4
8
*
WD105
NOMESCO Finland
Cystostatic therapy of methastized malignancy
+∞
8.4
8
*
TJF80
NOMESCO Finland
Ostomy education
+∞
8.4
8
*
R82.8
ICD-10 Finland
Abnormal findings on cytological and histological examination of urine
+∞
8.4
8
*
D41.2
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Ureter
+∞
8.4
8
*
JN4BD
NOMESCO Finland
Extensive body CT
7.1
8.3
20
33
JN3AD
NOMESCO Finland
Abdominal CT examination
4.2
8.2
25
71
ZXE10
NOMESCO Finland
More than one and less than three hours
3.0
7.9
55
264
C44.31
ICD-10 Finland
Basocellular carcinoma of the skin on another or unspecified part of the face
48.2
7.8
9
*
KC1EE
NOMESCO Finland
Ultrasound measurement of residual urine
3.4
7.4
33
122
ZX070
NOMESCO Finland
Intensity modified radiotherapy
+∞
7.4
7
*
WD325
NOMESCO Finland
Demanding therapy of methastized malignancy with biomodifiers
+∞
7.4
7
*
YL1BD
NOMESCO Finland
Extensive CT examination of pelvis for dose design of radiotherapy
+∞
7.4
7
*
U76
ICPC
Malignant neoplasm of bladder
+∞
7.4
7
*
C64.88
ICD-10 Finland
Other malignant neoplasm of kidney, except renal pelvis
+∞
7.4
7
*
YL1AD
NOMESCO Finland
CT examination of pelvis for dose design of radiotherapy
+∞
7.4
7
*
C68.8
ICD-10 Finland
Malignant neoplasm: Overlapping lesion of urinary organs
+∞
7.4
7
*
308
Kela drug reimbursment
Alprostadil, sildenafil and combination product containing aviptadil and phentolamine
+∞
7.4
7
*
L01BC06
ATC
capecitabine; oral
+∞
7.4
7
*
U99
ICPC
Urinary disease other
24.1
6.8
9
*
N02AB03
ATC
fentanyl; nasal, sublingual, transdermal
13.3
6.7
11
9
ZXE20
NOMESCO Finland
More than three and less than five hours
3.5
6.7
27
93
PJD44
NOMESCO Finland
Excision of iliac lymph nodes
73.6
6.5
7
*
TKW99
NOMESCO Finland
Other minor surgical procedure in urology
73.6
6.5
7
*
8130/2-C67.9
ICD-O-3
Papillary urothelial carcinoma, non-invasive of bladder, NOS
+∞
6.3
6
*
8090/3-C44.9
ICD-O-3
Basal cell carcinoma, NOS, of skin, NOS
+∞
6.3
6
*
ZX090
NOMESCO Finland
Other technic of radiotherapy
+∞
6.3
6
*
L03AA02
ATC
filgrastim; parenteral
+∞
6.3
6
*
KH1YT
NOMESCO Finland
Percutaneous implantation of endoprothesis with radiological guidance
+∞
6.3
6
*
WB113
NOMESCO Finland
Multiple adjuvant cytostatic therapy
+∞
6.3
6
*
L02AE02
ATC
leuprorelin; implant, parenteral
+∞
6.3
6
*
YX9AD
NOMESCO Finland
Other CT eamination for dose design of radiotherapy
+∞
6.3
6
*
KCC20
NOMESCO Finland
Cystoprostatourethrectomy
+∞
6.3
6
*
A04AD12
ATC
aprepitant; systemic
+∞
6.3
6
*
C79.5
ICD-10 Finland
Secondary malignant neoplasm of bone and bone marrow
+∞
6.3
6
*
TPH15
NOMESCO Finland
Insertion of central venous catheter through external or internal jugular vein
6.7
6.2
15
25
U07
ICPC
Urine symptom/complaint other
3.9
6.2
20
59
GD1AA
NOMESCO Finland
Thorax X-ray examination
2.6
6.1
71
431

LabWAS

↥
OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
cases
controls
unit
-log10(p)
N cases
N controls
63
35
37.13
84.62
6.2
1.7
—
—
—
0
0
78
293
5.82
20.01
7.3
3.1
—
—
—
0
0
28
18
19.92
18.64
1.5
1.1
—
—
—
0
0
34
64
7.04
18.58
1.6
1.0
—
—
—
0
0
80
387
4.26
12.98
3.8
2.4
—
—
estimate
—
0
0
58
237
3.82
11.78
3.7
1.5
—
—
—
0
0
44
155
3.92
10.99
11.2
6.4
105.20
104.59
mmol/l
0.31
44
155
63
282
3.62
10.96
9.6
3.0
0.37
0.35
e6/l
0.04
55
210
69
333
3.55
10.56
9.2
3.1
284.03
279.63
e6/l
0.01
57
259
65
311
3.40
9.93
6.3
4.1
—
—
—
0
0
29
86
4.14
9.05
15.2
9.8
—
—
—
0
0
59
278
3.23
9.05
3.3
2.1
—
—
—
0
0
69
363
3.14
8.64
10.9
3.7
574.63
114.03
e6/l
0.71
59
265
95
609
3.78
8.39
12.8
4.7
—
32.08
—
0
12
39
157
3.21
7.60
10.5
3.2
2.16
1.55
e6/l
0.22
25
82
33
122
3.36
7.37
7.7
3.7
1.17
1.30
mmol/l
0.07
27
99
79
477
2.95
7.27
10.0
3.6
9.29
13.63
umol/l
4.08
79
447
33
127
3.21
6.87
7.6
3.8
7.34
7.38
ph
1.93
23
76
41
184
2.87
6.49
2.2
1.7
29.10
29.06
s
0.02
41
175
74
467
2.55
5.69
15.1
5.2
4.78
4.55
e9/l
0.24
62
396
68
416
2.48
5.54
8.3
3.5
32.07
34.73
g/l
3.11
63
386
79
521
2.54
5.42
15.4
18.3
1.29
1.41
inr
0.98
66
429
72
473
2.32
4.73
7.3
3.9
51.88
0.00
estimate
0.48
24
99
71
467
2.29
4.61
7.4
3.9
0.00
0.00
estimate
-0.00
21
92
71
480
2.19
4.15
7.3
4.0
0.00
0.00
estimate
-0.00
23
88
14
38
4.04
3.95
1.1
1.3
—
—
—
0
0
71
500
2.04
3.50
13.9
6.7
1.21
1.20
mmol/l
0.38
60
422
56
364
2.02
3.44
7.1
3.5
6.46
6.21
ph
0.84
28
200
46
283
2.02
3.26
7.8
4.8
—
—
—
0
0
28
142
2.27
3.24
12.7
7.2
-1.91
1.41
mmol/l
3.13
23
120
47
292
2.01
3.24
8.1
3.6
7.37
7.39
ph
2.65
40
208
58
392
1.94
3.11
8.0
4.9
3.19
3.05
%
0.14
52
363
58
393
1.93
3.07
8.1
5.0
0.73
0.63
%
0.52
52
365
58
394
1.92
3.04
8.1
5.0
9.55
9.13
%
0.54
52
365
28
146
2.20
3.03
12.7
7.0
7.39
7.42
ph
0.93
13
94
15
59
2.76
2.92
17.7
9.0
15.78
15.59
%
0.11
15
59
17
73
2.55
2.80
1.5
1.3
—
—
—
0
0
18
80
2.47
2.77
6.5
3.1
—
—
—
0
0
57
397
1.84
2.68
8.2
5.0
20.94
24.85
%
1.78
52
372
62
448
1.80
2.55
8.4
4.8
0.19
0.21
e9/l
0.30
50
377
53
372
1.77
2.35
19.8
10.8
0.00
0.00
e9/l
-0.00
41
292
14
60
2.51
2.32
6.6
2.8
0.56
0.59
%
0.21
14
60
41
269
1.80
2.27
8.0
4.2
0.00
0.00
estimate
-0.00
17
87
20
102
2.15
2.27
5.8
3.4
4.74
4.58
kpa
0.12
20
96
5
9
5.74
2.23
1.2
2.1
8.50
12.66
%
—
5
9
5
9
5.74
2.23
1.4
1.1
21.92
22.07
ng/l
—
5
9
15
68
2.38
2.22
1.6
1.5
—
—
—
0
0
6
14
4.45
2.18
3.0
1.2
31.73
80.46
u/ml
—
6
14
17
83
2.22
2.14
2.6
2.7
0.33
0.42
e6/l
0.20
17
78
59
436
1.70
2.13
8.5
4.7
0.71
0.62
e9/l
1.12
44
365
14
63
2.39
2.10
6.6
2.8
1.25
1.01
%
0.62
14
63
59
438
1.69
2.08
8.5
4.7
0.04
0.04
e9/l
0.61
44
367
59
444
1.65
1.94
8.6
4.8
1.57
1.75
e9/l
1.04
47
383
14
66
2.27
1.91
7.0
3.2
—
—
—
0
0
36
248
1.65
1.62
3.3
2.7
405.63
370.67
umol/l
0.94
30
203
40
286
1.60
1.55
2.5
2.3
3.04
2.83
mg/l
0.24
31
239
15
81
1.97
1.48
9.3
1.7
497.60
388.01
nmol/l
1.04
15
72
7
28
2.59
1.47
9.3
3.9
—
—
—
0
0
13
67
2.06
1.44
1.6
1.3
—
—
—
0
0
14
76
1.95
1.36
8.3
4.6
193.68
103.40
ng/l
1.29
14
64
5
18
2.85
1.30
1.4
3.7
5.60
17.10
pmol/l
—
5
18
46
357
1.47
1.19
8.7
4.0
0.00
0.00
estimate
-0.00
16
71
22
146
1.62
1.13
3.4
1.8
—
—
—
0
0
29
213
1.48
0.97
1.3
1.3
—
—
—
0
0
23
164
1.50
0.88
5.6
3.7
—
—
—
0
0
6
31
1.98
0.85
9.7
5.5
1.62
1.35
mmol/l
—
6
31
13
81
1.68
0.85
6.3
4.2
—
—
—
0
0
94
863
1.42
0.80
30.9
15.5
—
—
—
0
0
0
27
0.00
0.78
0.0
1.0
—
—
—
0
0
60
517
1.32
0.76
5.0
4.6
5.23
2.18
ug/l
0.50
49
457
9
56
1.66
0.74
5.6
4.5
—
—
—
0
0
14
93
1.57
0.73
4.4
3.8
7.40
7.41
ph
0.58
14
76
11
69
1.65
0.71
5.7
3.9
0.50
0.90
%
—
6
20
32
254
1.36
0.70
9.6
4.1
—
—
—
0
0
0
21
0.00
0.60
0.0
1.2
—
2.13
—
0
15
0
22
0.00
0.60
0.0
1.4
—
113.53
—
0
17
0
23
0.00
0.59
0.0
4.8
—
29.26
—
0
18
10
66
1.56
0.54
6.2
4.0
0.20
0.18
%
—
5
17
15
109
1.43
0.54
2.4
1.9
—
—
—
0
0
21
263
0.76
0.50
3.3
4.0
—
—
—
0
0
31
258
1.27
0.49
6.7
3.5
0.00
0.00
estimate
-0.00
14
69
89
834
1.27
0.48
5.8
5.8
6.09
6.14
mmol/l
0.16
78
744
72
662
1.22
0.45
46.4
20.8
14.35
13.81
%
3.20
72
646
58
635
0.83
0.41
6.3
3.8
15.11
14.95
pmol/l
0.17
50
558
0
15
0.00
0.41
0.0
1.7
—
8.51
—
0
15
0
15
0.00
0.41
0.0
1.2
—
89.32
—
0
15
0
15
0.00
0.41
0.0
2.3
—
0.52
—
0
9
28
235
1.25
0.41
1.6
1.9
876.05
1168.87
nmol/l
1.18
22
180
0
17
0.00
0.41
0.0
1.9
—
16.48
—
0
17
5
34
1.49
0.41
1.2
1.2
—
—
—
0
0
9
66
1.39
0.39
1.3
1.3
—
—
—
0
0
0
19
0.00
0.39
0.0
2.0
—
9.79
—
0
19
5
36
1.41
0.38
3.6
1.9
431.60
69.27
ug/min
—
5
25
32
278
1.21
0.34
3.2
2.8
0.65
0.83
ug/l
0.93
24
197
14
110
1.31
0.33
1.1
1.2
—
—
—
0
0
10
74
1.38
0.33
1.4
1.3
—
—
—
0
0
53
486
1.16
0.31
2.1
2.2
94.45
89.74
pmol/l
0.35
35
253
13
103
1.29
0.29
1.2
1.5
—
—
—
0
0
49
448
1.16
0.29
5.8
4.5
70.60
50.92
ng/l
0.27
43
353
5
71
0.69
0.27
3.8
2.6
5.80
6.09
ph
—
5
58
0
11
0.00
0.21
0.0
1.1
—
1.55
—
0
11
0
11
0.00
0.21
0.0
1.1
—
0.80
—
0
11
0
11
0.00
0.21
0.0
1.0
—
338.85
—
0
11
0
10
0.00
0.21
0.0
1.1
—
—
—
0
0
0
10
0.00
0.21
0.0
1.0
—
—
—
0
0
0
10
0.00
0.21
0.0
1.9
—
—
—
0
0
0
12
0.00
0.21
0.0
1.2
—
—
—
0
0
23
257
0.87
0.19
2.0
2.0
321.94
392.53
pmol/l
1.29
18
209
41
381
1.12
0.18
4.4
4.1
—
—
—
0
0
36
389
0.89
0.18
3.3
3.3
6.63
7.67
mmol/l
0.80
29
326
5
69
0.71
0.17
1.0
1.4
—
—
—
0
0
37
398
0.90
0.17
4.1
4.1
8.51
8.31
mg/mmol
0.03
30
252
14
123
1.16
0.13
2.1
2.1
61.00
60.80
e9/l
—
6
89
69
667
1.08
0.12
49.2
22.2
329.14
332.12
g/l
2.38
69
662
87
851
1.08
0.10
5.5
6.6
2.43
2.42
mmol/l
0.04
80
771
7
65
1.08
0.08
1.4
1.6
—
—
—
0
0
77
783
0.95
0.05
6.3
5.0
2.09
2.00
mu/l
0.20
66
687
80
788
1.05
0.04
4.4
4.7
1.21
1.23
mmol/l
0.21
73
701
84
829
1.05
0.04
7.9
7.9
40.95
41.10
mmol/mol
0.05
76
759
83
821
1.04
0.02
4.7
5.6
1.39
1.40
mmol/l
0.09
76
739
23
223
1.04
0.01
9.6
4.2
1.02
1.02
kg/l
0.67
17
153
83
825
1.02
0.00
5.0
5.7
4.26
4.25
mmol/l
0.04
77
748
0
6
0.00
0.00
0.0
6.2
—
25.67
—
0
6
0
5
0.00
0.00
0.0
1.0
—
758.00
—
0
5
0
6
0.00
0.00
0.0
1.3
—
—
—
0
0
0
6
0.00
0.00
0.0
1.3
—
176.50
—
0
6
0
5
0.00
0.00
0.0
2.2
—
—
—
0
0
0
5
0.00
0.00
0.0
1.0
—
0.47
—
0
5
0
6
0.00
0.00
0.0
1.3
—
—
—
0
0
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
0
6
0.00
0.00
0.0
1.0
—
44.83
—
0
6
0
5
0.00
0.00
0.0
6.0
—
5.00
—
0
5
0
6
0.00
0.00
0.0
1.3
—
—
—
0
0
0
6
0.00
0.00
0.0
1.3
—
—
—
0
0
0
6
0.00
0.00
0.0
1.0
—
89.83
—
0
6
0
5
0.00
0.00
0.0
1.0
—
217.40
—
0
5
0
5
0.00
0.00
0.0
1.2
—
128.40
—
0
5
0
5
0.00
0.00
0.0
2.4
—
7.70
—
0
5
5
49
1.02
-0.00
6.0
2.0
1178.80
1387.75
ug/l
—
5
44
0
7
0.00
-0.00
0.0
4.1
—
35.71
—
0
7
0
7
0.00
-0.00
0.0
2.0
—
—
—
0
0
0
9
0.00
-0.00
0.0
1.2
—
—
—
0
0
0
9
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
7
0.00
-0.00
0.0
1.1
—
1.67
—
0
7
0
7
0.00
-0.00
0.0
1.4
—
—
—
0
0
0
8
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
7
0.00
-0.00
0.0
1.4
—
2.63
—
0
7
0
7
0.00
-0.00
0.0
1.4
—
0.38
—
0
7
0
8
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
7
0.00
-0.00
0.0
1.4
—
8.46
—
0
7

Mortality – FinRegistry

↥

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

Relationships between endpoints

↥

Index endpoint: C3_URINARY_TRACT_NAS – Malignant neoplasm of other and unspecified urinary organs

GWS hits: -

This endpoint is excluded from FinRegistry analyses (omitted endpoint).